The Role of Artificial Intelligence in Nephrology Clinical Trials
Year: 2024
Type: article
Abstract: 1The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 2The Division of Data Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, NY 3The Barbara T Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY aCorresponding Author: Girish N Nadkarni, MD, MPH, One Gustave L Levy Place, Box 1003, New York, NY-10029. [email protected]
Authors: Lili Chan, Girish N. Nadkarni
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1458057177, G243407756, G250158837, G3258664390, G5731736530, G8184380712, Application of Machine Learning to Identify Obstructive Sleep Apnea Subgroups at Risk for Atherosclerosis Progression and Cardiovascular Disease Events (OSA-GRANDE), Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy
OpenAlex ID: W4401540368
